The Mounjaro Injection Price Increase Explained — and What It Means for You

The biggest misconception: the list price rise means all private prices rose equally

The most common assumption circulating since September 2025 is that Eli Lilly's list-price change translated into a uniform, predictable rise across every provider. It didn't work that way. Private clinics and pharmacies set their own prices, and those prices absorb not just the medicine cost but consultation fees, prescription charges, dispensing costs, delivery, and clinical oversight, or they don't, in which case those extras appear as line items at checkout.

What the Lilly price change did do is establish a new floor. Mounjaro at the higher doses cannot realistically be supplied at the pre-September 2025 headline prices without something being stripped out of the service. If you're seeing prices that look dramatically lower than the range widely reported since the change, the useful question is: what's missing?

The full breakdown of how Mounjaro injection pricing is structured covers the factors that move the number month to month, including how dose progression affects cost.

What headline private prices often leave out

A quoted monthly price for a prescription medicine can mean almost anything. Some providers include the consultation and prescription fee. Many don't. Delivery charges, clinical check-in calls, dose-review appointments, and aftercare support are all commonly sold separately, or quietly absent altogether.

This matters more now than it did before September 2025. When the list price was lower, the gap between a bare-bones supply and a full-service package was smaller in absolute terms. At current price levels, a provider absorbing all of those costs into one figure is making a genuine promise; one advertising a low headline number almost certainly isn't.

If you're comparing prices for a specific dose, our guide to the 5mg pen price illustrates how the same dose can carry a meaningfully different total cost depending on what the provider wraps around it. The broader cost overview covers the full dose range.

Why nume is not trying to be the cheapest option, and what that decision includes

We won't pretend otherwise: you can find lower advertised prices. That's a deliberate outcome of how we've structured our service, not an oversight.

Every treatment order through nume includes a free consultation, free prescription, and the medicine itself, plus free next-working-day tracked delivery once your prescriber approves. Aftercare is available seven days a week. Your consultation lands on the desk of a named GPhC-registered Independent Prescriber, not a piece of software, the same day you submit it. There are no hidden fees and no subscriptions. If treatment isn't right for you clinically, you won't be charged.

Our prescribers also review every repeat order individually. That's relevant in the context of the price increase: when doses change (and progression through the Mounjaro schedule is the norm, not the exception) a real clinical check before each supply is part of responsible practice, not an upsell. The background to the September 2025 price increase has more on why dose matters so much to total cost, and if you're starting at the lowest dose, our page on what the 2.5mg injection costs explains what to expect at that stage of treatment. You can also read about our clinical team to understand who reviews your care.

One practical note: once your pen arrives, it lives in the fridge, anywhere from the dedicated door shelf to next to the milk works fine, as long as temperatures stay between 2°C and 8°C. Routine matters with injectable treatments, and having a clinical team available seven days helps when questions come up between doses.

A price rise is not the right moment to look for a cheaper, less-scrutinised source

The irony of a significant list-price increase is that it pushes some patients toward sellers who promise to sidestep it. The MHRA has been clear that counterfeit and illegally traded weight-loss pens are a real and growing problem, seizures of fraudulent stock reached approximately 20 million doses (around £45 million in street value) across 2025, and the first illicit UK manufacturing site producing fake tirzepatide pens was raided in October of that year. Fake pens have contained insulin. That is not a theoretical risk.

Any legitimate supply of Mounjaro in the UK travels through the licensed supply chain, is dispensed by a pharmacy you can verify on the GPhC pharmacy register, and requires a valid prescription from a clinician who has actually assessed you. Sellers offering it without clinical assessment, through social-media channels, or at prices that assume no dispensing or oversight costs are not an alternative, they're a risk. The MHRA encourages anyone who encounters a suspect seller to report it via the Yellow Card scheme.

For anyone wondering whether a lower-cost alternative medicine exists, this page addresses that question directly. And if you'd like to understand the full picture of what private weight-loss treatment can offer, our treatment overview is a good place to start.